You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NRIX Sale Disclosure
Hansen Gwenn · SEC Form 4 · Filed Aug 5, 2026
Sale
Calculated transaction value
$64.34K
Hansen Gwenn Chief Scientific Officer
NRIX
Nurix Therapeutics
NRIX
Transaction date
Aug 4, 2026
Public filing date
Aug 5, 2026
Filing lag
Filed 1 day later
NRIX daily price context
Close on/before transaction
$24.69
Aug 4, 2026
First close after public filing
$25.12
Aug 5, 2026
30-day return after filing
+4.06%
Through Sep 4, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,611 shares @ $24.64
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001817160-26-000015
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$100.14K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nurix Therapeutics, Inc. NRIX Current | Sale | Aug 4, 2026 | $64.34K |
| Nurix Therapeutics, Inc. NRIX | Sale | Aug 4, 2026 | $35.8K |